Corgenix Medical Corp., of Denver, said it inked a collaboration agreement with Eli Lilly and Co., of Indianapolis, to develop diagnostic technology to support an undisclosed Lilly oncology pipeline program.
Agenus Inc., Lexington, Mass., started enrollment of a Phase II study with Prophage G-200 (heat shock protein peptide complex-96 or HSPPC-96) vaccine in combination with Avastin (bevacizumab, Genentech/Roche) for treatment of recurrent glioblastoma multiforme in adult patients.
Upsher-Smith Laboratories Inc., of Maple Grove, Minn., completed a global Phase III trial for USL255 (extended-release topiramate), an internally developed program for the management of epilepsy in adults.
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5423
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST